Janssen Pharmaceuticals has issued a Xarelto recall for 13,500 bottles of the blood thinner after discovering microbial contamination in a sample of the drug. The drugs were reportedly manufactured in a Puerto Rico facility that had recently undergone $225 million in upgrades by Janssen’s parent company Johnson & Johnson.
Janssen has had to issue drug recalls due to contamination before, including 5,000 vials of Risperdal after common mold was found inside. A patient reportedly issued a contamination complaint for Xarelto, which was confirmed and led to a nationwide recall.
Xarelto is a blood thinner that has been on the market for 3 years. Many patients have reported serious side effects associated with the drug, including blood clots and uncontrolled bleeding. Nearly 2,000 adverse events have been linked to Xarelto, including 183 deaths.